These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7668 related articles for article (PubMed ID: 25543409)

  • 61. Differential expression of p52 and RelB proteins in the metastatic and non-metastatic groups of uveal melanoma with patient outcome.
    Singh MK; Singh L; Chosdol K; Pushker N; Saini N; Meel R; Bakhshi S; Sen S; Kashyap S
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):2969-2982. PubMed ID: 31612319
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
    Mallikarjuna K; Vaijayanthi P; Krishnakumar S
    Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?
    Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S
    Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
    Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
    Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression of bcl-2 in uveal malignant melanoma.
    Jay V; Yi Q; Hunter WS; Zielenska M
    Arch Pathol Lab Med; 1996 May; 120(5):497-8. PubMed ID: 8639055
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expression of Raf Kinase Inhibitor Protein (RKIP) is a predictor of uveal melanoma metastasis.
    Caltabiano R; Puzzo L; Barresi V; Cardile V; Loreto C; Ragusa M; Russo A; Reibaldi M; Longo A
    Histol Histopathol; 2014 Oct; 29(10):1325-34. PubMed ID: 24763848
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.
    Schefler AC; Koca E; Bernicker EH; Correa ZM
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1541-1545. PubMed ID: 31065847
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibitor of apoptosis proteins gene expression and its correlation with prognostic factors in primary and metastatic uveal melanoma.
    Lederman M; Meir T; Zeschnigk M; Pe'er J; Chowers I
    Curr Eye Res; 2008 Oct; 33(10):876-84. PubMed ID: 18853322
    [TBL] [Abstract][Full Text] [Related]  

  • 69. p53 expression in uveal malignant melanomas.
    Jay V; Yi Q; Hunter WS; Zielenska M
    Pathology; 1996 Nov; 28(4):306-8. PubMed ID: 9007946
    [TBL] [Abstract][Full Text] [Related]  

  • 70. PAUPAR lncRNA suppresses tumourigenesis by H3K4 demethylation in uveal melanoma.
    Ding X; Wang X; Lin M; Xing Y; Ge S; Jia R; Zhang H; Fan X; Li J
    FEBS Lett; 2016 Jun; 590(12):1729-38. PubMed ID: 27214741
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Elevated blood β-2 microglobulin is associated with tumor monosomy-3 in patients with primary uveal melanoma.
    Triozzi PL; Elson P; Aldrich W; Achberger S; Tubbs R; Biscotti CV; Singh AD
    Melanoma Res; 2013 Feb; 23(1):1-7. PubMed ID: 23196330
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [HLA class I antigen expression correlates with histological cell type in uveal melanoma].
    Dithmar S; Crowder J; Jager MJ; Vigniswaran N; Grossniklaus HE
    Ophthalmologe; 2002 Aug; 99(8):625-8. PubMed ID: 12227276
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intraocular lymphatics in ciliary body melanomas with extraocular extension: functional for lymphatic spread?
    Heindl LM; Hofmann TN; Schrödl F; Holbach LM; Kruse FE; Cursiefen C
    Arch Ophthalmol; 2010 Aug; 128(8):1001-8. PubMed ID: 20697000
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma.
    Karlsson M; Boeryd B; Carstensen J; Frånlund B; Gustafsson B; Kågedal B; Sun XF; Wingren S
    Eur J Cancer; 1996 Feb; 32A(2):357-62. PubMed ID: 8664054
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor.
    Wang Y; Liu M; Jin Y; Jiang S; Pan J
    Cancer Lett; 2017 Aug; 400():47-60. PubMed ID: 28455241
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prognostic value of apoptosis inducing factor in uveal melanoma.
    Krasnik V; Furdova A; Svetlosakova Z; Kobzova D; Gergisakova H; Feketeova L; Svetlosak M; Barta A; Babal P
    Neoplasma; 2017; 64(2):262-268. PubMed ID: 28043154
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Butyrophilin-Like 9 (BTNL9) Suppresses Invasion and Correlates with Favorable Prognosis of Uveal Melanoma.
    Jiang Z; Liu F
    Med Sci Monit; 2019 Apr; 25():3190-3198. PubMed ID: 31039142
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transscleral optical spectroscopy of uveal melanoma in enucleated human eyes.
    Krohn J; Svenmarker P; Xu CT; Mørk SJ; Andersson-Engels S
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5379-85. PubMed ID: 22729436
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Massive intracorneal invasion of a ciliary body melanoma.
    Seregard S
    Acta Ophthalmol (Copenh); 1994 Apr; 72(2):257-9. PubMed ID: 8079635
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PRDX3 is associated with metastasis and poor survival in uveal melanoma.
    Ramasamy P; Larkin AM; Linge A; Tiernan D; McAree F; Horgan N; Moriarty P; Beatty S; Murphy CC; Clynes M; Kennedy S; Meleady P
    J Clin Pathol; 2020 Jul; 73(7):408-412. PubMed ID: 31771972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 384.